1. Treating to Target in MS

3. Clinical Treatment Outcomes

4. Measuring Disability

5. NEDA

6. Brain MRI Guidelines

7. Baseline MRI in Patients With MS

8. Minimal Evidence of Disease Activity

9. Modified Rio Score

10. Patient Education About Relapses

11. MRI Scans in Relapse

12. Evolving Definition of NEDA

13. Improved Functioning in MS

14. Re-Treating Induction DMT vs NEDA

15. Cognition in MS

17. Cumulative vs Annual NEDA

18. Current and Proposed Concepts of NEDA

19. NEDA With Early DMT Initiation

20. ASCEND: Natalizumab in Progressive MS

21. Stopping a DMT

22. Conclusions

23. Abbreviations

24. Abbreviations (cont)